Additionally, several studies also indicate that miR-21 can modulate the chemosensitivity of cancer cells by targeting tumor-suppressors such as PTEN [60], programmed Cell Death 4 (PDCD4) [61,62], and FasL via serum miR-21 [63]. The gene discussed is PDCD4; the disease is neoplasm.